These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 35221159)
1. In desmoid-type fibromatosis cells sorafenib induces ferroptosis and apoptosis, which are enhanced by autophagy inhibition. Schut AW; Vriends ALM; Sacchetti A; Timbergen MJM; Alman BA; Al-Jazrawe M; Grünhagen DJ; Verhoef C; Sleijfer S; Wiemer EAC Eur J Surg Oncol; 2022 Jul; 48(7):1527-1535. PubMed ID: 35221159 [TBL] [Abstract][Full Text] [Related]
2. Autophagy inhibition overcomes sorafenib resistance in S45F-mutated desmoid tumors. Braggio D; Koller D; Jin F; Siva N; Zewdu A; Lopez G; Batte K; Casadei L; Welliver M; Strohecker AM; Lev D; Pollock RE Cancer; 2019 Aug; 125(15):2693-2703. PubMed ID: 30980399 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of sorafenib in desmoid-type fibromatosis: A need to review dose. Garg V; Gangadharaiah BB; Rastogi S; Upadhyay A; Barwad A; Dhamija E; Gamangatti S Eur J Cancer; 2023 Jun; 186():142-150. PubMed ID: 37062211 [TBL] [Abstract][Full Text] [Related]
4. Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells. Zhang Z; Yao Z; Wang L; Ding H; Shao J; Chen A; Zhang F; Zheng S Autophagy; 2018; 14(12):2083-2103. PubMed ID: 30081711 [TBL] [Abstract][Full Text] [Related]
5. Wnt targets genes are not differentially expressed in desmoid tumors bearing different activating β-catenin mutations. Timbergen MJM; Janssen ML; Verhoef C; Grünhagen DJ; Chibon F; Smid M; Sleijfer S; Wiemer EAC Eur J Surg Oncol; 2019 Apr; 45(4):691-698. PubMed ID: 30528042 [TBL] [Abstract][Full Text] [Related]
6. Treatment of Orbital Desmoid-type Fibromatosis With Sorafenib. Downie EM; Amend CE; Miranda A; Burkat CN Ophthalmic Plast Reconstr Surg; 2022 Sep-Oct 01; 38(5):e144-e147. PubMed ID: 35470290 [TBL] [Abstract][Full Text] [Related]
7. Novel pathogenic alterations in pediatric and adult desmoid-type fibromatosis - A systematic analysis of 204 cases. Trautmann M; Rehkämper J; Gevensleben H; Becker J; Wardelmann E; Hartmann W; Grünewald I; Huss S Sci Rep; 2020 Feb; 10(1):3368. PubMed ID: 32099073 [TBL] [Abstract][Full Text] [Related]
8. Artesunate synergistically promotes sorafenib‑induced apoptosis and ferroptosis in non‑Hodgkin lymphoma cells through inhibition of the STAT3 pathway. Chen Y; Tao H; Wang F; Wu P; Gao J; Zhang X; He Z; Zhou Z; Jia Y Oncol Rep; 2023 Jul; 50(1):. PubMed ID: 37326033 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical and Molecular Analyses Focusing on Mesenchymal Cells in Papillary Thyroid Carcinoma with Desmoid-Type Fibromatosis. Takada N; Mussazhanova Z; Hirokawa M; Nakashima M; Miyauchi A Pathobiology; 2018; 85(5-6):300-303. PubMed ID: 30223266 [TBL] [Abstract][Full Text] [Related]
10. CISD2 Promotes Resistance to Sorafenib-Induced Ferroptosis by Regulating Autophagy in Hepatocellular Carcinoma. Li B; Wei S; Yang L; Peng X; Ma Y; Wu B; Fan Q; Yang S; Li X; Jin H; Tang S; Huang M; Li H; Liu J Front Oncol; 2021; 11():657723. PubMed ID: 34485112 [TBL] [Abstract][Full Text] [Related]
11. Neuromuscular choristoma-associated desmoid-type fibromatosis: Establishing a nerve territory concept. Maldonado AA; Spinner RJ; Broski SM; Stone JJ; Howe BM; Carter JM Acta Neurochir (Wien); 2020 May; 162(5):1137-1146. PubMed ID: 31897730 [TBL] [Abstract][Full Text] [Related]
12. RNA-binding protein ZFP36/TTP protects against ferroptosis by regulating autophagy signaling pathway in hepatic stellate cells. Zhang Z; Guo M; Li Y; Shen M; Kong D; Shao J; Ding H; Tan S; Chen A; Zhang F; Zheng S Autophagy; 2020 Aug; 16(8):1482-1505. PubMed ID: 31679460 [TBL] [Abstract][Full Text] [Related]
13. Differential diagnosis and mutation stratification of desmoid-type fibromatosis on MRI using radiomics. Timbergen MJM; Starmans MPA; Padmos GA; Grünhagen DJ; van Leenders GJLH; Hanff DF; Verhoef C; Niessen WJ; Sleijfer S; Klein S; Visser JJ Eur J Radiol; 2020 Oct; 131():109266. PubMed ID: 32971431 [TBL] [Abstract][Full Text] [Related]
15. Clinical trials in desmoid-type fibromatosis in children and adults: A systematic review. van Maren SA; van Noesel MM; Husson O; van der Graaf WTA Pediatr Blood Cancer; 2022 Sep; 69(9):e29831. PubMed ID: 35714333 [TBL] [Abstract][Full Text] [Related]
16. Neuromuscular choristoma and circumferential nerve territory desmoid-type fibromatosis: imaging findings supporting a nerve-driven mechanism. Maldonado AA; Broski SM; Carter JM; Marek T; Howe BM; Spinner RJ J Neurosurg; 2024 Jan; 140(1):1-9. PubMed ID: 37382327 [TBL] [Abstract][Full Text] [Related]
17. Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma. Li ZJ; Dai HQ; Huang XW; Feng J; Deng JH; Wang ZX; Yang XM; Liu YJ; Wu Y; Chen PH; Shi H; Wang JG; Zhou J; Lu GD Acta Pharmacol Sin; 2021 Feb; 42(2):301-310. PubMed ID: 32699265 [TBL] [Abstract][Full Text] [Related]
18. Papillary thyroid carcinoma with desmoid-type fibromatosis: A clinical, pathological, and immunohistochemical study of 14 cases. Takada N; Hirokawa M; Ito M; Ito A; Suzuki A; Higuchi M; Kuma S; Hayashi T; Kishikawa M; Horikawa S; Miyauchi A Endocr J; 2017 Oct; 64(10):1017-1023. PubMed ID: 28794344 [TBL] [Abstract][Full Text] [Related]
19. GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis. Wang Q; Bin C; Xue Q; Gao Q; Huang A; Wang K; Tang N Cell Death Dis; 2021 Apr; 12(5):426. PubMed ID: 33931597 [TBL] [Abstract][Full Text] [Related]
20. Ursolic acid enhances the antitumor effects of sorafenib associated with Mcl-1-related apoptosis and SLC7A11-dependent ferroptosis in human cancer. Li H; Yu Y; Liu Y; Luo Z; Law BYK; Zheng Y; Huang X; Li W Pharmacol Res; 2022 Aug; 182():106306. PubMed ID: 35714823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]